{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:08:34Z","timestamp":1791403714167,"version":"4.3.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00277-025-06419-6","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:10:33Z","timestamp":1748045433000},"page":"2663-2669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Platelet-to-Neutrophil ratio as a predictor of risk of complications in sickle cell disease: a valuable insight for resource-limited settings"],"prefix":"10.1007","volume":"104","author":[{"given":"Chilota","family":"Efobi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnanna","family":"Ukpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyinye Ezinne","family":"Eze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Basil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"6","key":"6419_CR1","doi-asserted-by":"publisher","first-page":"e32701","DOI":"10.1097\/MD.0000000000032701","volume":"102","author":"C Elendu","year":"2023","unstructured":"Elendu C, Amaechi DC, Alakwe-Ojimba CE, Elendu TC, Elendu RC, Ayabazu CP et al (2023) Understanding sickle cell disease: causes, symptoms, and treatment options. Med (Baltim) 102(6):e32701. https:\/\/doi.org\/10.1097\/MD.0000000000032701","journal-title":"Med (Baltim)"},{"key":"6419_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4324\/9781003467748","volume-title":"Sickle cell disease in Sub-Saharan Africa: biomedical perspectives","author":"B Inusa","year":"2024","unstructured":"Inusa B, Nwankwo K, Azinge-Egbiri N, Bolarinwa B (2024) The clinical epidemiology of sickle cell disease in sub-Saharan Africa. Sickle cell disease in Sub-Saharan Africa: biomedical perspectives, 1st edn. Routledge, London, pp 1\u2013336. doi: https:\/\/doi.org\/10.4324\/9781003467748.","edition":"1"},{"issue":"4","key":"6419_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.chest.2015.12.016","volume":"149","author":"EM Novelli","year":"2016","unstructured":"Novelli EM, Gladwin MT (2016) Crises in sickle cell disease. Chest 149(4):1082\u20131093. https:\/\/doi.org\/10.1016\/j.chest.2015.12.016","journal-title":"Chest"},{"issue":"1","key":"6419_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ajh.26789","volume":"99","author":"LA de Ligt","year":"2024","unstructured":"de Ligt LA, Gaartman AE, Biemond BJ, Fijnvandraat K, van Bruggen R, Nur E (2024) Neutrophils in sickle cell disease: exploring their potential role as a therapeutic target. Am J Hematol 99(1):22\u201332. https:\/\/doi.org\/10.1002\/ajh.26789","journal-title":"Am J Hematol"},{"issue":"4","key":"6419_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.7754\/Clin.Lab.2023.230102","volume":"69","author":"G Dobie","year":"2023","unstructured":"Dobie G (2023) Sickle cell disease and thromboembolism: new insights on the pathophysiology, diagnosis, and treatment. Clin Lab 69(4):321\u2013330. https:\/\/doi.org\/10.7754\/Clin.Lab.2023.230102","journal-title":"Clin Lab"},{"key":"6419_CR6","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/annrheumdis-2023-224789","volume":"83","author":"I V\u00e1zquez-G\u00f3mez","year":"2024","unstructured":"V\u00e1zquez-G\u00f3mez I, Montolio-Chiva L, Lacasa-Molina J, Perea-Galera L, Taberner-Cort\u00e9s A, Robustillo-Villarino M et al (2024) Role of hematological indices in patients with psoriatic arthritis. Ann Rheum Dis 83:1516. https:\/\/doi.org\/10.1136\/annrheumdis-2023-224789","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6419_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.4314\/ejhs.v33i5.12","volume":"33","author":"CC Efobi","year":"2023","unstructured":"Efobi CC, Nri-Ezedi CA, Madu CS, Ikediashi CC, Ejiofor O, Ofiaeli CI (2023) Neutrophil-lymphocyte, platelet-neutrophil, and platelet-lymphocyte ratios as indicators of sickle cell anemia severity. Ethiop J Health Sci 33(5):821\u2013830. https:\/\/doi.org\/10.4314\/ejhs.v33i5.12","journal-title":"Ethiop J Health Sci"},{"key":"6419_CR8","doi-asserted-by":"publisher","first-page":"9820345","DOI":"10.1155\/2022\/9820345","volume":"2022","author":"H Wang","year":"2022","unstructured":"Wang H, Qing X, Wang H, Gu Y (2022) Association between platelet-to-neutrophil ratio (PNR) and clinical outcomes in STEMI patients after successful pPCI: A secondary analysis based on a cohort study. Cardiovasc Ther 2022:9820345. https:\/\/doi.org\/10.1155\/2022\/9820345","journal-title":"Cardiovasc Ther"},{"issue":"5","key":"6419_CR9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/bjh.12445","volume":"162","author":"OA Adisa","year":"2013","unstructured":"Adisa OA, Hu Y, Ghosh S, Aryee D, Osunkwo I, Ofori-Acquah SF (2013) Association between plasma free haem and incidence of vaso-occlusive episodes and acute chest syndrome in children with sickle cell disease. Br J Haematol 162(5):702\u2013705. https:\/\/doi.org\/10.1111\/bjh.12445","journal-title":"Br J Haematol"},{"issue":"4","key":"6419_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/ejh.13837","volume":"109","author":"HC Okoye","year":"2022","unstructured":"Okoye HC, Ezekekwu C, Nwagha TU, Korubo K, Omunakwe HE, Nnachi OC et al (2022) Prevalence of venous thromboembolism and its associations in a large Racially homogeneous population of sickle cell disease patients. Eur J Haematol 109(4):342\u2013349. https:\/\/doi.org\/10.1111\/ejh.13837","journal-title":"Eur J Haematol"},{"issue":"7","key":"6419_CR11","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.4103\/jfmpc.jfmpc_1675_23","volume":"13","author":"R Bhardwaj","year":"2024","unstructured":"Bhardwaj R, Agrawal U, Vashist P, Manna S (2024) Determination of sample size for various study designs in medical research: A practical primer. J Family Med Prim Care 13(7):2555\u20132561. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1675_23","journal-title":"J Family Med Prim Care"},{"key":"6419_CR12","doi-asserted-by":"publisher","first-page":"e947428","DOI":"10.12659\/MSM.947428","volume":"30","author":"DV Parums","year":"2024","unstructured":"Parums DV, Editorial (2024) The 2024 revision of the declaration of Helsinki and its continued role as a code of ethics to guide medical research. Med Sci Monit 30:e947428. https:\/\/doi.org\/10.12659\/MSM.947428","journal-title":"Med Sci Monit"},{"issue":"1","key":"6419_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/imr.13150","volume":"314","author":"LS Torres","year":"2023","unstructured":"Torres LS, Hidalgo A (2023) Neutrophils as drivers of vascular injury in sickle cell disease. Immunol Rev 314(1):41\u201357. https:\/\/doi.org\/10.1111\/imr.13150","journal-title":"Immunol Rev"},{"issue":"3","key":"6419_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00441-017-2756-7","volume":"371","author":"T Lisman","year":"2018","unstructured":"Lisman T (2018) Platelet\u2013neutrophil interactions as drivers of inflammatory and thrombotic disease. Cell Tissue Res 371(3):567\u2013576. https:\/\/doi.org\/10.1007\/s00441-017-2756-7","journal-title":"Cell Tissue Res"},{"key":"6419_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/JBM.S337065","volume":"13","author":"TYE Yousif","year":"2022","unstructured":"Yousif TYE (2022) Impact of abnormal leukocyte count in the pathophysiology of sickle cell anemia. J Blood Med 13:25\u201333. https:\/\/doi.org\/10.2147\/JBM.S337065","journal-title":"J Blood Med"},{"issue":"2","key":"6419_CR16","doi-asserted-by":"publisher","first-page":"104128","DOI":"10.1016\/j.lpm.2022.104128","volume":"52","author":"P Connes","year":"2023","unstructured":"Connes P, Renoux C, Joly P, Nader E (2023) Vascular pathophysiology of sickle cell disease. Presse Med 52(2):104128. https:\/\/doi.org\/10.1016\/j.lpm.2022.104128","journal-title":"Presse Med"},{"issue":"1","key":"6419_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s41927-024-00444-0","volume":"8","author":"M Masoumi","year":"2024","unstructured":"Masoumi M, Bozorgi M, Nourmohammadi Z, Mousavi MJ, Shariati A, Karami J (2024) Evaluation of hematological markers as prognostic tools in rheumatoid arthritis. BMC Rheumatol 8(1):75. https:\/\/doi.org\/10.1186\/s41927-024-00444-0","journal-title":"BMC Rheumatol"},{"key":"6419_CR18","doi-asserted-by":"publisher","first-page":"137016","DOI":"10.1016\/j.neulet.2022.137016","volume":"798","author":"L Geng","year":"2023","unstructured":"Geng L, Zuo L, Li H, Wang Y, Zhang Q, Ran J et al (2023) Association of platelet-to-neutrophil ratios with 1-year outcome and mortality in patients with acute ischemic stroke. Neurosci Lett 798:137016. https:\/\/doi.org\/10.1016\/j.neulet.2022.137016","journal-title":"Neurosci Lett"},{"issue":"7","key":"6419_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41569-021-00665-7","volume":"19","author":"DA Gorog","year":"2022","unstructured":"Gorog DA, Storey RF, Gurbel PA, Tantry US, Berger JS, Chan MY et al (2022) Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium. Nat Rev Cardiol 19(7):475\u2013495. https:\/\/doi.org\/10.1038\/s41569-021-00665-7","journal-title":"Nat Rev Cardiol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06419-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06419-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06419-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T02:37:30Z","timestamp":1749091050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06419-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6419"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06419-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6218867\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Health Research Ethics Committee of NAUTH, Nnewi, Anambra State with protocol number NAUTH\/CS\/66\/Vol.15\/VER.3\/120\/2022\/100 on January 2023 and was conducted in compliance with the Declaration of Helsinki. Informed and written consent was obtained from all participants before inclusion in the study and data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}